Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers

Clinical Drug Investigation

Volumn 16, Issue 4, 1998, Pages 329-333

  Sommers, De Klerk ^a,b   Snyman, Jacques R ^a   Van Wyk, Marieta ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Department of Pharmacology ^*  (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DEXFENFLURAMINE; FLUOXETINE; METOCLOPRAMIDE; SEROTONIN 4 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; AREA UNDER THE CURVE; ARTICLE; CELL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLOMERULOSA CELL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 7844242560     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816040-00007     Document Type: Article

References (27)

1. Li Kam Wa TC, Freestone S, Samson RR, et al. A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man. Br J Clin Pharmacol 1993; 36: 19-23
2. Shenker Y, Gross MD, Grekin RJ. Central serotonergic stimulation of aldosterone secretion. J Clin Invest 1985; 76: 1485-90
3. Maestri E, Camellini L, Rossi G, et al. Serotonin regulation of aldosterone secretion. Horm Metab Res 1988; 20: 457-9
4. Kosenkrantz H. A direct influence of 5-hydroxytryptamine on the adrenal cortex. Endocrinology 1959; 64: 355-62
5. Brownfield MS, Poff BC, Holzwarth MA. Ultrastructural immunocytochemical co-localization of serotonin and PNMT in adrenal medullary vesicles. Histochemistry 1985; 83: 41-6
6. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide - an updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451-92
7. Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 1988; 9; 334-41
8. 4) coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 1989; 340: 403-10
9. Lefebvre H, Contesse V, Delarue C, et al. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. J Clin Endocrinol Metab 1993; 77: 1662-6
10. 4 receptor. Eur J Clin Pharmacol 1996; 50: 371-3
11. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry 1994; 55 (9 Suppl. A): 34-9
12. Lemberger L, Bergstrom RF, Walen RL, et al. Fluoxetine: clinical pharmacology and physiologic disposition. J Clin Psychiatry 1985; 6 (3, Sect. 2): 14-9
13. Sommers De K, Van Wyk M, Snyman JR. Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine. Eur J Clin Pharmacol 1994; 46: 441-4
14. Gorard DA, Taylor TM, Medbak SH, et al. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Int Clin Psychopharmacol 1993; 8: 123-8
15. Spring B, Pingitore R. Serotonergic agents in obesity: from animal trials to human clinical studies. Rev Contemp Pharmacother 1991; 2: 61-78
16. Sommers De K, Snyman JR, Van Wyk M. Effects of metoclopramide, ondansetron and granisetron on aldosterone secretion in man. Eur J Clin Pharmacol 1993; 44: 337-9
17. 4 receptor. Eur J Clin Pharmacol 1996; 50: 371-3
18. Lefebvre H, Contesse V, Delarue C, et al. The serotonin-4 receptor agonist cisapride and angiotensin-II exert effects additive on aldosterone secretion in normal man. J Clin Endocrinol Metab 1995; 80: 504-7
19. Williams BC, Shaikh S, Edwards CRW. The specificity of ketanserin in the inhibition of steroid-induced steroidogenesis in the rat zona glomerulosa. J Hypertens 1984; 2: 559-61
20. Matsuoka H, Ishii M, Goto A, et al. Role of serotonin type 2 receptors in regulation of aldosterone production. Am J Physiol 1985; 249: E234-8
21. Rocco S, Boscaro M, D'Agostino D, et al. Effect of ketanserin on the in vitro regulation of aldosterone. J Hypertens 1986: 4: S51-4
22. Conn PJ, Bouhelal R, Sebben M, et al. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 1986; 83: 4086-8
23. 4) coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 1989; 340: 403-10
24. Sommers De K, Meyer EC, Van Wyk M. Effects of enhancement and antagonism of 5-hydroxytryptamine activity on metoclopramide-induced aldosterone secretion in man. Res Exp Med 1991; 191: 423-7
25. Garattini S, Bizzi A, Caccia S, et al. Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol 1988; 11 Suppl. 1: S8-32
26. Gobbi M, Frittoli E, Uslenghi T, et al. On the mechanisms by which d-fenfluramine and fluoxetine inhibit serotonin uptake: evidences from release studies. 5-hydroxytryptamine-CNS receptors and brain function [abstract P 32]. Congress on Serotonin; 1991 Jul 14-17; Birmingham University
27. 4 receptors coupled to adenylate cyclase [abstract book]. Second International Symposium on Serotonin, Houston, September 15-18, 1992: 53